“I would like for researchers to define a minimum amount of information that all participants in all clinical trials will get, and for that minimum to be consistent across all organizations.”
-Lane Rasberry, Clinical Trial Participant and Wikipedian
I, along with representatives from Novartis and Pfizer, announced a collaboration on November 12 at the Data to Knowledge to Action: Building New Partnerships technology conference in Washington, D.C. Our objective as a group is to build a consistent framework for clinical trial information to make it easier for patients and their families to find clinical trials that might be right for them.
By collaborating in this pre-competitive space, we hope to enable patient communities and patient-centric software companies to develop applications that help people match themselves with a study’s target profile across a variety of patient populations. We also hope to not only serve individuals looking for clinical trials, but to enroll trials faster and more efficiently—ultimately speeding drug development.
Earlier this summer, we invited patients, healthcare professionals, web developers and designers to show us how they would present information about clinical trials is a more engaging and patient-friendly way through our Clinical Trial Visualization Redesign Challenge.
Today, we are pleased to announce the winners of that challenge. The eight submissions below represent the most innovative and user-friendly approaches to presenting clinical trial information, according to our judging panel of patient advocates and healthcare professionals; and, in the case of the Popular Vote Award, according to the public. The teams and individuals who were selected were able to take complex, highly-technical, industry-focused clinical trial documents and transform them into interactive, engaging, patient-focused platforms for discovering and understanding clinical research.
We also would like to take this opportunity to thank our judges for this challenge, who volunteered their time, skill and insight to helping us select the winners. Read more about each of them and their unique qualifications on the ChallengePost site.
And the Winners Are…
Back in June, we asked technology professionals, designers, patients and clinicians to help us discover new ways to present clinical trial information. Those who accepted the challenge were given a standard clinical trial protocol, informed consent document and corresponding ClinicalTrials.gov webpage, and were asked to envision those materials in a more patient-friendly manner.
We were pleased to see so many teams take on the challenge. Lilly COI and ChallengePost staff have spent the last couple of weeks sorting through the wide range of unique and creative approaches that were submitted. Now, we need your help in selecting the “Popular Vote” prize winner!
How to Vote
While all submissions are viewable, in order to vote, you will need a verified ChallengePost account. Log in to your account, or sign up if you don’t already have one.
Photo by DIAC Images
Every day, scientists all over the world are working to discover new and promising treatment options for diseases like Alzheimer’s, Cancer, Diabetes, and Parkinson’s. But, unfortunately, many of those treatments never make it past the testing phase, due to difficulties in finding enough volunteers for clinical trials. According to a recent article in the Sacramento Bee, 85 percent of drug trials face delays because of difficulties attracting and retaining participants. And, enrollment rates in drug studies have dropped 20 percent since 2000.
The reasons for the drop are unclear. But, for patients who are considering clinical trials as an option, the complexity of finding the right trial and then fully understanding the requirements, risks and benefits almost certainly isn’t helping.
Once a patient does find a clinical trial for which she seems to be a good match, she may find that it just doesn’t fit her needs or lifestyle. Many trial protocols are created solely by sponsors and researchers who may not have taken patient perspectives into consideration. This means that they may have designed a trial with many barriers to entry, such as poor fit to local standards of care, lack of flexibility for the patients in scheduling appointments associated with the trial, and inconvenient locations.
At Lilly COI, we’re working to address the communication and protocol design issues through initiatives like our Clinical Trial Revisualization Design Challenge. And, fortunately, a number of clinical trial matching services have emerged in recent years to help patients find the right trials much more easily.